- Home
- LVLU vs VVOS Comparison
LVLU vs VVOS Comparison
Compare LVLU & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- VVOS
- Stock Information
- Founded
- LVLU 1996
- VVOS 2016
- Country
- LVLU United States
- VVOS United States
- Employees
- LVLU N/A
- VVOS N/A
- Industry
- LVLU Catalog/Specialty Distribution
- VVOS Medical Specialities
- Sector
- LVLU Consumer Discretionary
- VVOS Health Care
- Exchange
- LVLU Nasdaq
- VVOS Nasdaq
- Market Cap
- LVLU 18.4M
- VVOS 17.5M
- IPO Year
- LVLU 2021
- VVOS 2020
- Fundamental
- Price
- LVLU $0.28
- VVOS $4.20
- Analyst Decision
- LVLU Hold
- VVOS Strong Buy
- Analyst Count
- LVLU 2
- VVOS 2
- Target Price
- LVLU $1.00
- VVOS $6.10
- AVG Volume (30 Days)
- LVLU 778.0K
- VVOS 1.7M
- Earning Date
- LVLU 08-13-2025
- VVOS 08-13-2025
- Dividend Yield
- LVLU N/A
- VVOS N/A
- EPS Growth
- LVLU N/A
- VVOS N/A
- EPS
- LVLU N/A
- VVOS N/A
- Revenue
- LVLU $302,783,000.00
- VVOS $14,628,000.00
- Revenue This Year
- LVLU N/A
- VVOS $17.40
- Revenue Next Year
- LVLU $2.53
- VVOS $10.78
- P/E Ratio
- LVLU N/A
- VVOS N/A
- Revenue Growth
- LVLU N/A
- VVOS 9.47
- 52 Week Low
- LVLU $0.22
- VVOS $1.97
- 52 Week High
- LVLU $1.88
- VVOS $6.28
- Technical
- Relative Strength Index (RSI)
- LVLU 34.10
- VVOS 80.66
- Support Level
- LVLU $0.22
- VVOS $3.11
- Resistance Level
- LVLU $0.56
- VVOS $4.68
- Average True Range (ATR)
- LVLU 0.09
- VVOS 0.39
- MACD
- LVLU -0.02
- VVOS 0.19
- Stochastic Oscillator
- LVLU 15.25
- VVOS 90.57
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About VVOS Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.